Literature DB >> 14766862

Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes.

Nadia Liassine1, Raymond Auckenthaler, Marie-Christine Descombes, Michèle Bes, François Vandenesch, Jerome Etienne.   

Abstract

Among 10 strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolated in 2002 from patients with skin infections, seven harbored the Panton-Valentine leukocidin gene, two harbored the exfoliative toxin A gene, and one harbored neither of these genes. CA-MRSA isolates producing a variety of exotoxins are currently spreading in the Swiss community.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14766862      PMCID： PMC344453          DOI： 10.1128/JCM.42.2.825-828.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus.

Authors:  Rajan P Adhikari; Gregory M Cook; Iain Lamont; Selwyn Lang; Helen Heffernan; John M B Smith
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

Authors:  A V Groom; D H Wolsey; T S Naimi; K Smith; S Johnson; D Boxrud; K A Moore; J E Cheek
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

5.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Authors:  T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan.

Authors:  Takayuki Yamaguchi; Yoshiko Yokota; Jun Terajima; Tetsuya Hayashi; Martin Aepfelbacher; Masaru Ohara; Hitoshi Komatsuzawa; Haruo Watanabe; Motoyuki Sugai
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

7.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

8.  egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus.

Authors:  S Jarraud; M A Peyrat; A Lim; A Tristan; M Bes; C Mougel; J Etienne; F Vandenesch; M Bonneville; G Lina
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41.

Authors:  Sander Koning; Alex van Belkum; Susan Snijders; Willem van Leeuwen; Henri Verbrugh; Jan Nouwen; Mariet Op 't Veld; Lisette W A van Suijlekom-Smit; Johannes C van der Wouden; Cees Verduin
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

Authors:  Philippe Dufour; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Hervé Richet
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079
View more
  34 in total

1.  Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.

Authors:  Nuno A Faria; Duarte C Oliveira; Henrik Westh; Dominique L Monnet; Anders R Larsen; Robert Skov; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Zurich, Switzerland (2003): prevalence of type IV SCCmec and a new SCCmec element associated with isolates from intravenous drug users.

Authors:  Wei Qi; Miriam Ender; Frances O'Brien; Alexander Imhof; Christian Ruef; Nadine McCallum; Brigitte Berger-Bächi
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Multilocus sequence typing of methicillin-resistant Staphylococcus aureus from an area of low endemicity by real-time PCR.

Authors:  Carolina Berglund; Paula Mölling; Lennart Sjöberg; Bo Söderquist
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome.

Authors:  Norihisa Noguchi; Hidemasa Nakaminami; Setsuko Nishijima; Ichiro Kurokawa; Hiromu So; Masanori Sasatsu
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Blinded comparison of repetitive-sequence PCR and multilocus sequence typing for genotyping methicillin-resistant Staphylococcus aureus isolates from a children's hospital in St. Louis, Missouri.

Authors:  Robert S Liao; Gregory A Storch; Richard S Buller; Rachel C Orscheln; Elaine R Mardis; Jon R Armstrong; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

6.  Favorable outcome of pneumonia due to Panton-Valentine leukocidin-producing Staphylococcus aureus associated with hematogenous origin and absence of flu-like illness.

Authors:  C Alonso-Tarrés; M L Villegas; F J de Gispert; M C Cortés-Lletget; A Rovira Plarromaní; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

7.  Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital.

Authors:  Nadjia Ramdani-Bouguessa; Michèle Bes; Hélène Meugnier; Françoise Forey; Marie-Elisabeth Reverdy; Gerard Lina; François Vandenesch; Mohamed Tazir; Jerome Etienne
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital.

Authors:  A M Strandén; R Frei; H Adler; U Flückiger; A F Widmer
Journal:  Infection       Date:  2008-10-30       Impact factor: 3.553

9.  Sensitive and specific detection of staphylococcal epidermolysins A and B in broth cultures by flow cytometry-assisted multiplex immunoassay.

Authors:  Olivier Joubert; Daniel Keller; Anne Pinck; Henri Monteil; Gilles Prévost
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Emergence of community-associated methicillin-resistant Staphylococcus aureus associated with pediatric infection in Cambodia.

Authors:  Kheng Chheng; Sarah Tarquinio; Vanaporn Wuthiekanun; Lina Sin; Janjira Thaipadungpanit; Premjit Amornchai; Ngoun Chanpheaktra; Sarinna Tumapa; Hor Putchhat; Nicholas P J Day; Sharon J Peacock
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.